SKWD vs WRB: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
WRB is the larger of the two ($26.92B market cap): the incumbent the market prices for continued execution (15.02x forward earnings, beta 0.29). SKWD is the smaller challenger ($2.31B), cheaper on forward earnings (10.29x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
SKWD vs WRB: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | SKWD | WRB | What it tells you |
|---|---|---|---|
| Market cap | $2.31B | $26.92B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 10.29 | 15.02 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 13.23 | 14.93 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.33 | 0.29 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 65% of range | 60% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: SKWD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how SKWD and WRB affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. SKWD and WRB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined SKWD and WRB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Skyward Specialty Insurance (SKWD) do?
Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. The US business is organised into nine underwriting divisions, each with dedicated leadership: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premiums from those divisions came to ~$667.9M, up 14.1% year over year, with Global Agriculture nearly doubling to ~$111.9M and Accident & Health up 57.8% to ~$95.5M, while Captives, Energy Solutions and Global Property each contracted by mid-teens percentages. Management calls the approach "Rule Our Niche", and the intended consequence is that close to half the book sits in lines that do not track the property catastrophe cycle. On January 1, 2026 the company closed a ~$559.1M purchase of Apollo Group Holdings, paid for with ~$371.1M of cash and 3,679,332 Skyward shares valued at $51.11 each. Apollo underwrites through Syndicates 1969 and 1971 with its own capital and provides managing agency services to nine Lloyd's syndicates in total, which hands Skyward a fee stream on premium it does not carry: ~$318.1M of fee-generating gross written premium in the quarter.
What does W. R. Berkley (WRB) do?
W.R. Berkley Corporation is one of the larger commercial property and casualty insurers in the United States, organized into two reporting segments: an Insurance segment that writes commercial lines, excess and surplus (E&S) coverage, and specialty risks through dozens of separately branded operating units, and a Reinsurance and Monoline Excess segment that assumes risk on a treaty and facultative basis. The decentralized, niche-by-niche structure lets each unit price complex or hard-to-place risks that standard carriers avoid, which is where the company earns much of its underwriting margin.
SKWD vs WRB: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- SKWD drivers: Apollo turns an underwriter into a fee earner as well; Nine divisions that grow and shrink on their own schedules.
- WRB drivers: Specialty and E&S underwriting discipline; Rising investment income on the float.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest exposure is reserve adequacy. For WRB, property and casualty insurance is cyclical, and commercial pricing has been softening after several strong years, which could compress future margins if rate increases no longer outpace claims inflation.
SKWD or WRB: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick SKWD if you believe its drivers more; WRB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the SKWD and WRB guides.
SKWD vs WRB: the full fundamentals
SKWD. A screener's 1.3x price-to-sales figure carries almost no signal for SKWD, because insurance revenue is premium the company has already promised to pay claims against. The multiple that carries information is price to book, and at ~2.0x the stock sits well below the ~4x to 5x that the market has awarded the fastest-growing US excess and surplus underwriters, and above the ~1.3x to 1.5x typical of carriers whose returns hover near their cost of capital. On tangible book the gap narrows, since ~$471.2M of the equity base is now goodwill and intangibles from Apollo.
WRB. WRB reported record Q1 2026 operating income of about $514 million and net income to common stockholders near $515 million, up more than 20% year over year, on revenue of roughly $3.69 billion. The trailing P/E in the mid-teens is typical for a high-quality P&C insurer, and the headline dividend yield near 0.55% understates total cash returned because Berkley frequently pays special dividends on top of its regular quarterly payout.
Headline figures (approximate, August 2026): SKWD shows revenue (ttm) ~$1.73B for the twelve months to June 30, 2026, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. The 2026 half-year figure of ~$965.4M includes Apollo for the first time, alongside ~$878.5M of net earned premium, ~$57.8M of net investment income, ~$22.7M of underwriting fee income and ~$3.9M of commission and fee income., earnings and operating earnings Second-quarter 2026 net income of ~$49.0M, or ~$1.07 per diluted share, and operating income of ~$59.2M, or ~$1.30 per diluted share, up 46% year over year. First-half net income was ~$98.8M (~$2.17 diluted) and operating income ~$116.1M (~$2.55 diluted). Full-year 2025 delivered ~$170.0M of net income (~$4.07 diluted) and ~$167.4M of adjusted operating income (~$4.00). Trailing twelve-month diluted EPS is ~$4.30., underwriting metrics Combined ratio of 89.5% in the second quarter of 2026 (62.3% loss, 27.2% expense), 87.6% excluding 1.9 points of catastrophe loss, versus 89.3% for full-year 2025 and 92.3% for 2024. By segment, Skyward Specialty ran 86.9% and Apollo 97.6%. Gross written premiums were ~$740.6M in the quarter and ~$2,166.2M for full-year 2025; ceded written premium of ~$254.9M in the quarter left ~$485.6M net written and ~$444.5M net earned, a 65.6% net retention., book value and returns Book value per share of $28.55 at June 30, 2026, up 14.6% from $24.92 at December 31, 2025, which had itself risen 26% during 2025. Fully diluted book value per share was $27.20 and tangible shareholders' equity ~$861.9M, or roughly $19.41 per share. Annualized return on equity was 15.7% for the quarter and 17.3% for the half; annualized operating ROE was 19.0% and 20.4%, and operating return on tangible equity 28.2% and 26.0%.; WRB shows market cap ~$27B, revenue (ttm) ~$14.5B, net income (q1 2026) ~$515M, combined ratio (q1 2026) ~90.7%.
The bottom line: SKWD vs WRB
SKWD and WRB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined SKWD and WRB exposure against your real portfolio. It is not an investment adviser.
Wondering how SKWD or WRB fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Skyward Specialty Insurance with AI
Connect the broker you already use and ask Walnut's AI how SKWD fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between SKWD and WRB?
+
Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. W.R. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is SKWD or WRB the better stock?
+
Neither is universally better. WRB is the larger incumbent; SKWD is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, SKWD or WRB?
+
On forward P/E (as of August 2026), SKWD trades at 10.29x and WRB at 15.02x, so SKWD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both SKWD and WRB?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of SKWD vs WRB?
+
SKWD: The largest exposure is reserve adequacy. Net loss reserves of ~$1,908.1M exceed shareholders' equity of ~$1,267.5M by half again, so a 5% deficiency across the book would consume roughly 7% of book value before tax. Growth compounds that: Global Agriculture premium nearly doubled year over year and Accident & Health rose 57.8%, and immature accident years in fast-growing lines are where estimation error tends to appear two or three years later. A second, less discussed exposure is credit. Reinsurance recoverables of ~$1,411.6M are larger than the entire equity base, and Skyward remains liable to policyholders if a reinsurer fails to pay. The company has also been retaining more risk itself, with net retention on a written basis rising to 65.6% in the second quarter of 2026 from 58.0% a year earlier, which raises the loss volatility that reaches the income statement. Apollo brings its own set. Goodwill and intangibles of ~$471.2M now equal ~37% of equity, including $200M of indefinite-lived syndicate capacity that is tested for impairment rather than amortised, and the 10-Q states that the assessment of internal control over financial reporting excludes Apollo while integration continues. The Lloyd's segment ran a 97.6% combined ratio in the quarter with 5.4 points of catastrophe loss attributed primarily to the conflict in the Middle East, a reminder that the acquired book carries political and war exposure the US divisions largely do not. Pricing is the background condition: management's own 2026 guidance assumes a 90.5% to 91.5% combined ratio, above the 89.5% delivered in the first half, which implies an expected second-half deterioration. Alternative and strategic investments have been a persistent drag, costing ~$8.1M in the first half of 2026 after ~$11.5M in 2025. Chief Financial Officer Mark Haushill is retiring effective March 31, 2027. WRB: Property and casualty insurance is cyclical, and commercial pricing has been softening after several strong years, which could compress future margins if rate increases no longer outpace claims inflation. Reserve adequacy is a persistent risk: if past claims prove more costly than booked, prior-year reserve charges hit earnings. Catastrophe exposure from hurricanes, wildfires, and severe convective storms can spike losses in any quarter. Investment income depends on interest rates, so a sharp decline in yields would slow that engine, and credit or equity losses in the portfolio would flow through book value. Finally, the shares typically trade at a premium to book value, so any slip in the sub-91% combined ratio could pressure the multiple.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell SKWD or WRB; figures are approximate and dated (as of August 2026). Verify current data before investing.